Do pregnancy outcomes of women with false-positive early gestational diabetes mellitus differ from those of women with normal glucose tolerance?

Table 2 Pregnancy and neonatal outcomes

	Normal glucose tolerance group n = 1774	False-positive early GDM group n = 67	p-value	aRC or aOR	95%CI
Gestational age (weeks)	39.2 [38.2–40.1]	39.2 [38.2–40.1]	0.41	0.273	-0.289–4.118
Birth weight (g)	2982 [2700–3233]	3088 [2778–3312]	0.15	46.88	-20.463–114.236
LGA	159 (9.0%)	6 (9.0%)	1.00	0.868	0.361–2.087
SGA	168 (9.5%)	4 (6.0%)	0.20	0.460	0.142–1.497
Macrosomia	11 (0.62%)	0 (0%)
Shoulder dystocia	13 (0.73%)	0 (0%)
Gestational weight gain (kg)	10.3 [7.7–12.7]	8.4 [4.6–11.8]	0.003	-0.681	-1.200- -0.162
HDP	140 (7.9%)	12 (18%)	0.003	1.34	0.834–3.277
Cesarean delivery	470 (26%)	24 (36%)	0.093	1.023	0.603–1.738
Emergency cesarean delivery	221 (13%)	12 (18%)	0.19	1.134	0.589–2.182
NICU admission	296 (17%)	10 (15%)	0.74	0.782	0.370–1.567
Neonatal hypoglycemia^a	10 (0.5%)	4 (6.0%)	0.001	11.3	3.125–41.407
RDS	22 (1.2%)	0(0%)
Neonatal hyperbilirubinemia	174 (9.8%)	8 (12%)	0.53	1.175	0.544–2.535

Values are expressed as median [IQR] or n (%). Moreover, aOR and aRC have been adjusted for age and pre-pregnant BMI
GDM Gestational diabetes mellitus, LGA Large for gestational age, SGA Small for gestational age, HDP Hypertensive disorder of pregnancy, NICU Neonatal intensive care unit, RDS Respiratory distress syndrome, aOR Adjusted Odds ratio, aRC Adjusted Regression Coefficient
^aIn the false-positive early GDM group, blood glucose level was measured in all neonates after birth. In the NGT group, the blood glucose level of neonates was only measured if neonates were SGA or LGA, if NICU admission was required, or if judged necessary by the neonatologist

ISSN: 1472-6823